Announce Date | 02/20/2025 |
EPS Normalized Actual | $-0.55058 (Miss by $-0.65058) |
EPS GAAP Actual | $-0.55058 (Miss by $-0.65058) |
Revenue Actual | $2.335B |
Revenue Surprise | Beat by $2335M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.417 |
EPS GAAP Estimate | $0.417 |
Revenue Estimate | $2.90214575B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.35 | 4.81 | 2.30434 | 2.38561 | 1 |
Dec 2027 | 1.8 | 6.28 | 1.76503 | 1.82728 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.55 | -0.55 | 2.335B | -6.81% | 2335M |
FQ3 2024 (Sep 2024) | 0.0621 | 0.0621 | 2.476B | -7.79% | 2476M |
FQ2 2024 (Jun 2024) | 0.11 | 0.11 | 2.738B | -0.37% | 2738M |
FQ1 2024 (Mar 2024) | 0.0207 | 0.0207 | 2.735B | 3.33% | 2735M |
FQ4 2023 (Dec 2023) | -0.27 | -0.27 | 2.494B | -2.45% | 2494M |
FQ3 2023 (Sep 2023) | 0.13 | 0.13 | 2.669B | 5.02% | 2669M |
FQ2 2023 (Jun 2023) | 0.21 | 0.21 | 2.748B | 5.9% | 2748M |
FQ1 2023 (Mar 2023) | 0.19 | 0.19 | 2.644B | 100% | 2644M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.417
Consensus Revenue Estimates
2.90214575B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.71 | -- | 0.69141 | 0.72626 | 1 |
FQ2 2027 (Jun 2027) | 0.59 | -- | 0.57455 | 0.60351 | 1 |
FQ1 2027 (Mar 2027) | 0.43 | -- | 0.41874 | 0.43985 | 1 |
FQ4 2026 (Oct 2026) | 0.5 | -- | 0.49136 | 0.50967 | 0 |
FQ3 2026 (Jul 2026) | 0.54 | -- | 0.53067 | 0.55044 | 0 |
FQ2 2026 (Jun 2026) | 0.57 | -- | 0.55637 | 0.58359 | 0 |
FQ1 2026 (Mar 2026) | 0.45 | -- | 0.43924 | 0.46073 | 0 |
FQ4 2025 (Oct 2025) | 0.41195 | 233.51 | 0.40483 | 0.41992 | 1 |
FQ3 2025 (Jul 2025) | 0.41323 | 84.97 | 0.40609 | 0.42122 | 1 |
FQ2 2025 (Jun 2025) | 0.417 | 73.62 | 0.40703 | 0.42694 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.65B | -- | 2.59B | 2.69B | 2 |
FQ2 2027 (Jun 2027) | 2.56B | -- | 2.51B | 2.6B | 2 |
FQ1 2027 (Mar 2027) | 2.41B | -- | 2.36B | 2.45B | 2 |
FQ4 2026 (Oct 2026) | 2.91B | -- | 2.87B | 2.95B | 2 |
FQ3 2026 (Jul 2026) | 3.03B | -- | 2.99B | 3.08B | 2 |
FQ2 2026 (Jun 2026) | 3.05B | -- | 3B | 3.11B | 2 |
FQ1 2026 (Mar 2026) | 2.87B | -- | 2.81B | 2.92B | 2 |
FQ4 2025 (Oct 2025) | 2.79B | 16.42 | 2.76B | 2.84B | 1 |
FQ3 2025 (Jul 2025) | 2.87B | 13.63 | 2.83B | 2.91B | 1 |
FQ2 2025 (Jun 2025) | 2.9B | 5.66 | 2.85B | 2.96B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.55 | -0.55 | 100% | |
FQ3 2024 (Sep 2024) | 0.0621 | 0.0621 | 100% | |
FQ2 2024 (Jun 2024) | 0.11 | 0.11 | 100% | |
FQ1 2024 (Mar 2024) | 0.0207 | 0.0207 | 100% | |
FQ4 2023 (Dec 2023) | -0.27 | -0.27 | 100% | |
FQ3 2023 (Sep 2023) | 0.13 | 0.13 | 100% | |
FQ2 2023 (Jun 2023) | 0.21 | 0.21 | 100% | |
FQ1 2023 (Mar 2023) | 0.19 | 0.19 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.34B | $2335M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.48B | $2476M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.74B | $2738M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.74B | $2735M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.49B | $2494M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.67B | $2669M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.75B | $2748M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.64B | $2644M | 100% |